Skadden, Arps, Slate, Meagher & Flom has advised Hong Kong biotech startup Prenetics on its planned $459 million Nasdaq listing via a merger with special purpose acquisition company (SPAC) Artisan Acquisition, which was represented by Kirkland & Ellis.

The transaction values Prenetics at an enterprise value of $1.25 billion with a combined equity value of up to $1.7 billion, making Prenetics the first Hong Kong unicorn to become a publicly listed company.

The Skadden team was led by partners Jonathan Stone, Peter Huang, and Paloma Wang and Victor Hollender.

To contact the editorial team, please email ALBEditor@thomsonreuters.com.